Cervical Cancer Vaccination In Chandrapur is the fifth most common cancer in humans and the second most common in women worldwide. In developing countries, it is the leading cause of cancer-related death among women. The most significant risk factor for cervical intraepithelial neoplasia or invasive cervical cancer is infection with the sexually transmitted human papillomavirus (HPV).
Once, Globally, there are about 510,000 new cases of cervical cancer each year, resulting in approximately 288,000 deaths. Unlike many other cancers, cervical cancer often occurs early and affects women during their productive years. The incidence increases in women aged 30 to 34 and peaks between 55 and 65 years, with a median age of 38 years (ranging from 21 to 67 years).
Once, The cervical cancer vaccine protects against HPV, particularly the types most commonly associate with cervical cancer (HPV types 16 and 18) and other types that cause genital warts (HPV types 6 and 11).
Firstly, Cervical cancer is one of the most frequent cancers in women in India. India has about 365.71 million women over 15 years of age who are at risk. Current estimates show approximately 132,000 new cases and 74,000 deaths annually. This accounts for nearly one-third of global cervical cancer deaths. Indian women have a 2.5% cumulative lifetime risk and a 1.4% cumulative death risk from cervical cancer. About 6.6% of women in the general population are estimated to harbor cervical HPV infection at any time.
Therfore, Several cervical cancer research programs are currently active in India. The National Cancer Registry Programme, established by the Indian Council of Medical Research, acts as a cancer surveillance system. It collects data actively by visiting government and private hospitals, specialized cancer hospitals, and pathology laboratories to gather information on cancer cases. However, the cancer registry in India does not cover the entire country. It collects information only from a few urban and rural registries.